| MERCK KGAA O.N. | 115.50 / +0.61% |
| Date/Time | 01/17 / 17:35 |
| Chg. / Chg.(%) | 0.70 / +0.61% |
| Bid | - |
| Ask | - |
| Open | 115.10 |
| Previous Close | 114.80 |
| High | 115.80 |
| Low | 114.55 |
| Volume [EUR] | 69,427,084.60 |
| Volume [Units] | 602,467 |
| Price fixings | 2132 |
| ISIN | DE0006599905 |
| Security | MRK |
| Exchange | Xetra |
| Type | Stock |
| Exchange | Last | Volume | |
|---|---|---|---|
| Xetra | 115.50 |  |
602,467 |
| Cboe Europe .. | 115.05 | |
152,089 |
| London Inter.. | 115.50 | |
79,852 |
| Cboe Europe .. | 115.05 | |
58,598 |
| Turquoise | 115.20 | |
57,423 |
| TradeGate | 115.750 | |
2,464 |
| Stuttgart | 115.250 | |
2,105 |
| Frankfurt | 115.7000 | |
232 |
| Nasdaq Other.. | 127.4500 | |
110 |
| Hamburg | 115.55 | |
77 |
| Düsseldorf | 115.60 | |
35 |
| Borsa Italia.. | 115.40 | |
4 |
| München | 115.65 | |
2 |
| Vienna Globa.. | 115.10 | |
0 |
| Hannover | 115.10 |  |
0 |
| Berlin | 115.65 | |
0 |
| Lang & Schwa.. | 115.250 | |
|
| gettex | 115.500 | |
|
| SIX Swiss Ex.. | 102.20 | ||
| SIX Swiss Ex.. | 97.00 | ||
| EUREX | Options | ||
News
- FDA approves Astra Zeneca, Merck & Co. drug
12/30/2019 / 10:13 - TeleTrader - Merck to acquire ArQule for $2.7B
12/09/2019 / 23:36 - TeleTrader - Vaccinex Reports Third Quarter 2019 Financial Results and Provides Corporate Update
11/12/2019 / 14:00 - GlobeNewswire - Vaccinex Presents Updated Interim Data from a Phase 1b/2 Study of Pepinemab (VX15/2503) in Combination with Avelumab (BAVENCIO®) in Non-Small Cell Lung Cancer at the 34th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
11/09/2019 / 14:02 - GlobeNewswire - Merck says Q3 sales jump 12% YoY to $12.4B
10/29/2019 / 11:49 - TeleTrader
Real-time